Marksans

MARKSANS.NS

Tags: IN Healthcare Drug Manufacturers - General

Marksans Pharma Price (MARKSANS.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

453,160,000

(9.09)%

Market Cap of Marksans (MARKSANS.NS)

Market cap:

As of , MARKSANS.NS has a market cap of . This makes MARKSANS.NS the 453th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, a... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $130-358.7
Market Cap 91.61B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - General

ceo: Mr. Mark B. Saldanha
IPO Date: July, 19, 2002
Country: IN
Currency: INR
Headquaters: No Data
Employees: 1141

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: